These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23291092)

  • 1. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
    Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
    Pan WK; Li P; Guo ZT; Huang Q; Gao Y
    Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
    Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
    Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
    Holmes WJ; Mishra A; Gorst C; Liew SH
    J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol therapy for infantile haemangiomas: review of the literature.
    Zimmermann AP; Wiegand S; Werner JA; Eivazi B
    Int J Pediatr Otorhinolaryngol; 2010 Apr; 74(4):338-42. PubMed ID: 20117846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of airway hemangioma with propranolol.
    Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
    Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The change of serum vascular endothelial growth factor and matrix metalloproteinases-9 in proliferative hemangioma treated with propranolol].
    Zhao ZF; Lü RR; Huo R; Fu HB; Xu GQ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Sep; 27(5):359-61. PubMed ID: 22259987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of serum and urinary vascular endothelial growth factor-A and epidermal growth factor-like domain 7 in proliferating hemangioma treated with propranolol].
    Bin L; Manli C; Jie L; Xiaopeng Y; Zhaoquan L; Zhongcheng G
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2014 Oct; 32(5):441-5. PubMed ID: 25490818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
    Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
    Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.
    Storch CH; Hoeger PH
    Br J Dermatol; 2010 Aug; 163(2):269-74. PubMed ID: 20456345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
    Phillips RJ; Penington AJ; Bekhor PS; Crock CM
    J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol for infantile hemangioma: Effect on plasma vascular endothelial growth factor.
    Ozeki M; Nozawa A; Hori T; Kanda K; Kimura T; Kawamoto N; Fukao T
    Pediatr Int; 2016 Nov; 58(11):1130-1135. PubMed ID: 26991797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
    Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
    Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol was effective in treating cutaneous infantile haemangiomas in Thai children.
    Techasatian L; Komwilaisak P; Panombualert S; Uppala R; Jetsrisuparb C
    Acta Paediatr; 2016 Jun; 105(6):e257-62. PubMed ID: 26919396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Propranolol therapy for periocular and orbital infantile haemangiomas].
    Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
    Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol for infantile haemangiomas: a review.
    Starkey E; Shahidullah H
    Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol.
    Pope E; Chakkittakandiyil A; Lara-Corrales I; Maki E; Weinstein M
    Br J Dermatol; 2013 Jan; 168(1):222-4. PubMed ID: 22762503
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of infantile haemangiomas of the orbit with propranolol.
    Li YC; McCahon E; Rowe NA; Martin PA; Wilcsek GA; Martin FJ
    Clin Exp Ophthalmol; 2010 Aug; 38(6):554-9. PubMed ID: 20491798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature.
    Oksiuta M; Matuszczak E; Debek W; Dzienis-Koronkiewicz E; Hermanowicz A
    J Matern Fetal Neonatal Med; 2016; 29(1):64-8. PubMed ID: 25385271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study.
    Tiwari P; Pandey V; Gangopadhyay AN; Sharma SP; Gupta DK
    Oral Maxillofac Surg; 2016 Mar; 20(1):73-7. PubMed ID: 26481918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.